Low-grade inflammation in white-coat hypertension

被引:0
作者
Ozdogan, Mustafa [1 ]
Bozcuk, Hakan [1 ]
Coban, Erkan [1 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Internal Med, TR-07070 Antalya, Turkey
来源
MEDICAL SCIENCE MONITOR | 2007年 / 13卷 / 12期
关键词
white-coat hypertension; essential hypertension; hs-CRP; cardiovascular risk;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: C-reactive protein (CRP), a marker of systemic low-grade inflammation, is frequently elevated in essential hypertension and predicts cardiovascular prognosis independently of conventional risk factors. The risk profile of white-coat hypertension is not yet completely clear. The aim of this study was to determine the levels of high-sensitivity CRP (hs-CRP) in white-coat hypertensive subjects. Material/ Methods: Thirty-six age-, sex-, and body mass index-matched white-coat hypertensive subjects, 36 essential hypertensive patients, and 36 normotensive subjects were included in the study. Results: Hs-CRP levels were significantly higher in the essential hypertensive and white-coat hypertensive groups than in the normotensive group (0.66 +/- 0.29, 0,47 +/- 0.32, and 0.27 +/- 0.22 mg/dl, respectively, p<0.001). It was also higher in the essential hypertensive group than in the white-coat hypertensive group) (p=0.014). Conclusions: Our data show that patients with white-coat hypertension have higher hs-CPW levels than normotensive patients and this may he an indication of increased risk.
引用
收藏
页码:CR570 / CR573
页数:4
相关论文
共 50 条
  • [21] Microalbuminuria in children with primary and white-coat hypertension
    Seeman, Tomas
    Pohl, Michael
    Palyzova, Daniela
    John, Ulrike
    PEDIATRIC NEPHROLOGY, 2012, 27 (03) : 461 - 467
  • [22] The clinical significance of white-coat and masked hypertension
    Verdecchia, Paolo
    Angeli, Fabio
    Gattobigio, Roberto
    Borgioni, Claudia
    Castellani, Claudia
    Sardone, Mariagrazia
    Reboldi, Giahpaolo
    BLOOD PRESSURE MONITORING, 2007, 12 (06) : 387 - 389
  • [23] Microalbuminuria in children with primary and white-coat hypertension
    Tomáš Seeman
    Michael Pohl
    Daniela Palyzova
    Ulrike John
    Pediatric Nephrology, 2012, 27 : 461 - 467
  • [24] CLINICAL-SIGNIFICANCE OF WHITE-COAT HYPERTENSION
    GOSSE, P
    BOUGALEB, M
    EGLOFF, P
    LEMETAYER, P
    CLEMENTY, J
    JOURNAL OF HYPERTENSION, 1994, 12 : S43 - S47
  • [25] Prevalence of white-coat and masked hypertension in national and international registries
    Gorostidi, Manuel
    Vinyoles, Ernest
    Banegas, Jose R.
    de la Sierra, Alejandro
    HYPERTENSION RESEARCH, 2015, 38 (01) : 1 - 7
  • [26] Complications of white-coat hypertension compared to a normotensive and hypertensive population
    Taher, Ziad Abdullah
    Khayyat, Waleed W.
    Balubaid, Marwan M.
    Tashkandi, Mohamed Y.
    Alamoudi, Saeed M.
    Kinsara, Abdulhalim Jamal
    HEART VIEWS, 2021, 22 (01): : 8 - 12
  • [27] Masked and White-Coat Hypertension Moving to African Americans
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (20) : 2170 - 2172
  • [28] White-Coat Effect Is Uncommon in Patients With Refractory Hypertension
    Siddiqui, Mohammed
    Judd, Eric K.
    Oparil, Suzanne
    Calhoun, David A.
    HYPERTENSION, 2017, 70 (03) : 645 - 651
  • [29] Blood Pressure Measurement and Treatment Decisions Masked and White-Coat Hypertension
    Kario, Kazuomi
    Thijs, Lutgarde
    Staessen, Jan A.
    CIRCULATION RESEARCH, 2019, 124 (07) : 990 - 1008
  • [30] Risk of stroke in white-coat hypertension: A multinational registry
    Verdecchia, P
    Reboldi, G
    Schillaci, G
    Angeli, F
    Schwartz, JE
    Imai, Y
    Kario, K
    Pickering, TG
    L'Italien, GJ
    Lapuerta, P
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 65A - 65A